FGFR GENE ALTERATIONS
Clinical trials for FGFR GENE ALTERATIONS explained in plain language.
Never miss a new study
Get alerted when new FGFR GENE ALTERATIONS trials appear
Sign up with your email to follow new studies for FGFR GENE ALTERATIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill could fight bladder cancer without surgery
Disease control Recruiting nowThis Phase 2 trial tests an oral drug called TYRA-300 in 90 adults with a low-grade, intermediate-risk bladder cancer that has not invaded muscle. The cancer must have a specific genetic change (FGFR3 alteration). Participants take a daily tablet for up to 2 years. The main goal …
Matched conditions: FGFR GENE ALTERATIONS
Phase: PHASE2 • Sponsor: Tyra Biosciences, Inc • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New pill targets genetic weakness in tough cancers
Disease control Recruiting nowThis early-stage trial tests a new daily pill called TYRA-430 in 100 adults with advanced liver cancer or other solid tumors that have specific genetic changes. The main goals are to find the safest dose and check for side effects. Researchers will also look for signs that the dr…
Matched conditions: FGFR GENE ALTERATIONS
Phase: PHASE1 • Sponsor: Tyra Biosciences, Inc • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New pill targets rare cancer gene in last-resort patients
Disease control Recruiting nowThis study tests an experimental drug called E7090 in people with advanced or returning solid tumors that have a specific change in the FGFR gene. About 75 participants will receive the drug to see if it can shrink tumors and control the disease. The goal is to offer a new option…
Matched conditions: FGFR GENE ALTERATIONS
Phase: PHASE2 • Sponsor: National Cancer Center, Japan • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC